Group 1 - The market may have overlooked positive signals for Shenzhou International from Nike's performance, as Nike's apparel sales grew by 4% year-on-year, despite being lower than the previous quarter's 7% growth due to a high base effect [1] - Nike's apparel sales in North America and Europe recorded positive growth during the period, which is beneficial for Shenzhou International, as approximately 40% of its sales come from these regions [1] - In the Greater China region, Nike's apparel sales only declined by 6% year-on-year, significantly less than the 20% drop in footwear sales; this region now accounts for only 11% of Nike's total sales, limiting its impact on Shenzhou International [1] Group 2 - Morgan Stanley's report indicates that Nike's Q2 FY2026 performance negatively affected Shenzhou International's stock performance; however, the market tends to view Shenzhou International as a representative of the domestic sportswear sector in China, while over 75% of its sales come from markets outside China, suggesting resilience in other markets [2] - The recent decline in Shenzhou International's stock price presents a good buying opportunity, with a target price set at HKD 72 and a rating of "Overweight" [2]

Group 1 - Citi's report indicates that Nike (NKE.US) projects a low single-digit decline in revenue for Q3 of FY2026, aligning with market expectations of a 1% drop [1] - In Q2 performance, North America showed a strong recovery with a 9% revenue increase, primarily driven by a 24% growth in wholesale business, although this growth was largely offset by a 16% decline in revenue from Greater China [1] - Citi believes that if the stock price of Shenzhou International (02313) experiences a pullback due to Nike's cautious outlook, it would present a better buying opportunity, setting a target price of HKD 94 and a "buy" rating [1] Group 2 - Shenzhou International's management has recently provided conservative expectations, anticipating a slowdown in sales growth to mid-single digits in the second half of 2025, which is below Citi's previous forecast of high single digits [1] - Citi's projections are believed to largely reflect the impact of Nike's cautious outlook, but they expect Nike's sales orders for Shenzhou International in 2026 to remain flat rather than decline [1] - Based on visibility of orders from four major clients, Shenzhou International is still expected to achieve high single-digit sales growth in 2026 [1]

Core Viewpoint - Morgan Stanley's report indicates that Nike's Q2 FY2026 performance negatively impacted the stock performance of Shenzhou International, but the latter is positioned to benefit from resilience in markets outside China [1] Group 1: Nike's Performance - Nike's apparel sales grew by 4% year-over-year at constant currency, although this is lower than the previous quarter's 7% growth due to a high base effect [1] - Apparel sales in North America and Europe recorded positive growth during the period, which is beneficial for Shenzhou International as approximately 40% of its sales come from these regions [1] - In Greater China, Nike's apparel sales declined by only 6% year-over-year, significantly better than the 20% drop in footwear sales; this region now accounts for only 11% of Nike's total sales, limiting its impact on Shenzhou International [1] Group 2: Shenzhou International's Outlook - The market tends to view Shenzhou International as a representative of the domestic sportswear sector in China, but over 75% of its sales come from markets outside China, suggesting it may benefit more from resilience in other markets [1] - The recent decline in Shenzhou International's stock price presents a good buying opportunity, with Morgan Stanley setting a target price of HKD 72 and an "Overweight" rating [1]

Core Viewpoint - Morgan Stanley's research report indicates that Nike's Q2 FY2026 performance negatively impacted Shenzhou International's performance, but the market may overlook positive signals for Shenzhou from Nike's results [1] Group 1: Nike's Performance - Nike's apparel sales grew by 4% year-on-year in the quarter, although this was lower than the previous quarter's growth of 7%, attributed to a high base effect [1] - Nike's apparel sales in North America and Europe recorded positive growth during the period, which is beneficial for Shenzhou International as approximately 40% of its sales come from these regions [1] - In Greater China, Nike's apparel sales only declined by 6% year-on-year, significantly better than the 20% decline in footwear sales; this region now accounts for only 11% of Nike's total sales, limiting its impact on Shenzhou International [1] Group 2: Shenzhou International's Market Position - The market tends to view Shenzhou International as a representative of the domestic sportswear sector in China, but over 75% of its sales come from markets outside of China, suggesting it may benefit more from resilience in other markets [1] - The recent decline in Shenzhou International's stock price presents a good buying opportunity, with Morgan Stanley setting a target price of HKD 72 and maintaining an "Overweight" rating [1]

Market Overview - US inflation slowdown supports interest rate cut expectations, while the Bank of Japan raised rates by 25 basis points, leading to a rise in Hong Kong's three major indices. The Hang Seng Index increased by 0.75% to 25,690.53 points, with a total turnover of HKD 221.186 billion. The Hang Seng China Enterprises Index rose by 0.68%, and the Hang Seng Tech Index increased by 1.12% [1] Blue Chip Performance - Shenzhou International (02313) led the decline among blue chips, falling by 3.18% to HKD 60.95, with a turnover of HKD 490 million. Despite exceeding revenue and profit expectations, its net profit dropped by 32% year-on-year due to declining profit margins and ongoing pressures in direct sales [2] - Other blue chips included WuXi Biologics (02269), which rose by 4.4%, and Li Auto-W (02015), which increased by 3.81% [2] Sector Highlights - Large tech stocks mostly rose, with Tencent, Kuaishou, and Meituan gaining over 1%. The L3-level autonomous driving sector saw significant activity, with stocks like Xiaopeng Motors rising over 7% [3] - The pharmaceutical sector rebounded significantly, with companies like Kelun Pharmaceutical (06821) rising by 10.42% and WuXi Biologics (02269) increasing by 4.4% [4] - Lithium stocks also saw gains, with Ganfeng Lithium (01772) up by 1.87% and Tianqi Lithium (09696) rising by 1.72% [4] New Listings - New stocks showed a clear divergence, with Zhihui Mining (02546) soaring by 90.69% to HKD 8.6, while Xidi Intelligent Driving (03881) fell by 13.69% to HKD 227 [7] Company Developments - CIMC Group (02039) saw a strong performance, rising by 15.47% to HKD 8.88 after announcing a buyback plan for H-shares [8] - Changfei Optical Fiber (06869) surged by 12.01% to HKD 51.75, driven by signs of recovery in the optical fiber market [9] - China Duty Free Group (01880) saw its A and H shares rise by 6.88% to HKD 70.7, with expectations of increased sales due to optimized offshore duty-free shopping policies [10] - China Tobacco Hong Kong (06055) rose by 6.68% to HKD 34.48, supported by new regulations aimed at strengthening electronic cigarette oversight [11]

Group 1 - The core viewpoint of the report indicates that Nike's management has provided a guidance for a low single-digit decline in sales for the third fiscal quarter, which is seen as slightly negative for ODM suppliers like Shenzhou International [1] - Despite the cautious outlook from Nike, Shenzhou is expected to gain more market share in new product areas such as running, golf, and basketball jerseys this year [1] - Shenzhou's management has also given a conservative forecast, expecting mid-single-digit sales growth in the second half of 2025, which is lower than previous high single-digit predictions, reflecting the impact of Nike's latest outlook [1] Group 2 - Citi predicts that Nike's sales orders for Shenzhou will remain flat rather than decline in 2026, and with visibility on orders from the top four clients, Shenzhou's sales are expected to achieve high single-digit growth in 2026 [1] - The report suggests that if Shenzhou's stock price experiences a pullback due to Nike's cautious outlook, it may present a buying opportunity, maintaining a "buy" rating for Shenzhou with a target price of HKD 94 [1]

Group 1 - The Hang Seng Index rose by 0.65%, gaining 165 points to close at 25,663 points, while the Hang Seng Tech Index increased by 1.14%. The morning trading volume reached 97.5 billion HKD [1] - New listings in the Hong Kong stock market included Zhihui Mining (02546), which surged over 110% upon debut, and Xidi Zhijia (03881), which fell over 8% after its listing [1] - The U.S. Senate passed a revised version of the Biodefense Act as part of the National Defense Authorization Act for fiscal year 2026, leading to a significant rebound in pharmaceutical stocks, with WuXi Biologics (02269) rising over 6% and 3SBio (01530) increasing by 3.7% [1] Group 2 - HAP Pharmaceuticals-B (02142) saw a nearly 7% increase after signing a business development deal worth over 1 billion USD with Bristol-Myers Squibb [2] - China Duty Free Group (601888) (01880) rebounded nearly 7% after winning bids for two major duty-free projects at Shanghai airports, with market attention on the results of the Capital Airport tender [2] - Youjia Innovation (02431) surged over 12% as L3 large-scale deployment approaches, with the company having made forward-looking arrangements for L2+ and L4 [2] - Nine Dragons Paper (02689) rose over 3% as the industry leader announced a series of shutdown plans to support price and inventory levels before the Spring Festival [2] Group 3 - South Manganese (01091) increased by over 9% due to multiple factors driving the continuous rise in electrolytic manganese prices [3] Group 4 - Yangtze Optical Fibre (601869) (06869) rose over 10%, with a cumulative increase of over 30% in the past three days, driven by sustained demand for optical fibers and cables from AI [4] Group 5 - Ganwan (09890) increased by over 5% after issuing zero-coupon convertible bonds at a premium, raising 450 million HKD to enhance its "AI + gaming" strategy [5] Group 6 - Liqin Resources (02245) rose over 9% as Indonesia plans to significantly reduce its nickel ore production targets by 2026 [6] Group 7 - Shenzhou International (02313) fell over 3% as its major client Nike reported a 32% year-on-year decline in net profit for the second fiscal quarter [7]

Group 1 - Shenzhou International (02313.HK) experienced a decline of over 3%, specifically a drop of 3.02%, bringing its share price to HKD 61.05 [2] - The trading volume for Shenzhou International reached HKD 123 million [2]

Group 1 - The core point of the article is that Shenzhou International (02313) experienced a decline of over 3% in its stock price, attributed to the poor financial performance of its major client, Nike, which reported a 32% year-on-year drop in net profit for Q2 of fiscal year 2026 [1][1][1] - Nike's net profit fell from $1.16 billion in the same period last year to $792 million, despite revenue and earnings exceeding market expectations [1][1][1] - Revenue in Greater China for Nike decreased by 17% to $1.7 billion, with EBITDA dropping significantly by 49% [1][1][1] Group 2 - Citigroup recently downgraded its earnings forecast for Shenzhou International for 2025 to 2027 by 2%, lowering the target price from HKD 95 to HKD 94 while maintaining a "buy" rating [1][1][1] - The decline in Shenzhou's stock price may reflect management's conservative outlook on sales, which could present a buying opportunity, as the expected dividend yield for fiscal year 2026 is 4.8% and the projected compound annual growth rate for earnings per share over the next three years is 12% [1][1][1]

Core Viewpoint - Shenzhou International (02313) experienced a decline of over 3%, currently trading at HKD 61.05, with a transaction volume of HKD 123 million. This drop is linked to Nike's disappointing Q2 FY2026 earnings report, which led to a more than 10% drop in Nike's stock price [1] Group 1: Financial Performance - Nike's Q2 FY2026 report showed that despite revenue and profit exceeding market expectations, net profit fell by 32% year-on-year, dropping from USD 1.16 billion to USD 792 million [1] - Revenue in Greater China for Nike decreased by 17% year-on-year to USD 1.7 billion, with EBITDA declining significantly by 49% [1] Group 2: Analyst Insights - Citigroup recently revised its earnings forecast for Shenzhou International for 2025 to 2027 down by 2%, lowering the target price from HKD 95 to HKD 94 while maintaining a "Buy" rating [1] - The decline in Shenzhou International's stock price may reflect management's conservative outlook on sales, which could present a buying opportunity, as the expected dividend yield for FY2026 is 4.8% and the projected annual compound growth rate for earnings per share over the next three years is 12% [1]